ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: SA-PO729

Gonococcal Endocarditis-Associated Glomerulonephritis: Revisiting a Forgotten Enemy

Session Information

Category: Glomerular Diseases

  • 1303 Glomerular Diseases: Clinical‚ Outcomes‚ and Trials

Authors

  • Harris, Liliia, The University of Mississippi Medical Center, Jackson, Mississippi, United States
  • Sriperumbuduri, Sriram, The University of Mississippi Medical Center, Jackson, Mississippi, United States
  • Syed, Bushra, The University of Mississippi Medical Center, Jackson, Mississippi, United States
Introduction

Disseminated gonococcal infection is rare in the post-antibiotic era (0.5-3.0% cases) and can be complicated by infective endocarditis (IE) and glomerulonephritis (GN). We describe a unique case of rapidly progressive GN (RPGN) secondary to gonococcal IE coinciding with complement deficiency.

Case Description

A 61-year-old male with migratory polyarthritis, recurrent UTIs and conjunctivitis presented with diarrhea, arthralgia, and skin rash. On physical exam: purpuric rash involving forearms, thighs, nasal tip and cheeks; tenderness and swelling of the right shoulder and small joints of the right foot; bilateral chronic anterior uveitis.
On initial workup (Table 1): anemia, leukocytosis, sCr of 2.98 mg/dL from baseline 0.8. Urinalysis showed proteinuria, hematuria, sterile pyuria, WBC casts. Cefepime started for empiric sepsis (Figure 1). A skin biopsy was consistent with leukocytoclastic vasculitis. Steroids were initiated due to suspected RPGN and worsened sCr. On additional workup: elevated UPCR and low C3 complement level; on renal biopsy diffuse crescentic and exudative GN with C3 deposits; favors IRGN.
ECHO revealed a multi-lobular mass 1.9x2.6 cm on tricuspid valve (TV). Steroids were held due to concern for IE. Workup for culture-negative IE was unrevealing but metagenomics sequencing of microbial cell free DNA resulted positive for Neisseria gonorrhea. Functional testing of the complement pathway revealed normal CH50 and decreased AH50 activity. He received 6-weeks of Ceftriaxone with resolution of the TV vegetation and partial renal recovery with sCr of 1.27 mg/dL.

Discussion

Complement deficient patients are highly susceptible to Neisseria infections. Dysregulation of complement pathway predisposed to C3 glomerulopathy and concomitant infection provided a second hit contributing to severe GN. Treatment with antibiotics and steroids led to partial renal recovery; further research needed on role of immunosuppression for course and outcome of IRGN.

Admission laboratory results
WBC
Hemoglobin
ERS
CRP
sCr
BUN
Blood culture
Urine culture
Admission laboratory results
13.7 TH/cmm (4.0 –10.0)
5.7 g/dL (13.0 –17.0)
111 ml/hr (0.0 – 10.0)
13.6 mg/dL (0.0 -0.5)
2.98 mg/dL (0.67 – 1.17)
59 mg/dL (8-23)
No growth after 5 days
No growth
Complementary laboratory results
UPCR
Serum albumin
C3 complement
C4 complement
Complement total (CH50)
AH50, alternative complement pathway, functional
Mannose binding Lectin
HIV, HCV, HbsAg, HBC, HBS
Cyclic Citrullinated Peptide
Syphilis antibody (total)
ASO screen
ANA
SSA and SSB antibody
Rheumatoid factor
Glomerular Basement Membrane Antibodies
Cryoglobulin
ANCA
Kappa/Lambda Free light chain (FLC) ratio
IFE (urine/serum)
N. gonorrhea, urine
C. trachomatis, urine
Bartonella Hensalae, Quintana IgG Screen
Bartonella Hensalae, Quintana IgM Screen
Bartonella PCR (Blood)
Brucella Antibody IgG
Brucella Antibody IgM
Tropheryma whipplei PCR (Blood)
Blastomyces Antigen
Histoplasma Antigen Urine
Q Fever IgG Phase I Ab; II Ab
Q Fever IgM Phase I Ab, II Ab
Culture, AFB Blood
Legionella Antigen Urine
Culture, Fungus Blood
Karius test: Neisseria gonorrhoeae
Complementary laboratory results
3.3
3 gm/dl
46 mg/dl (90 – 180)
18 mg/dl (10 – 40)
42 U/ml (35-70)
Low, < 10 % of norm (> 46)
3390 ng/ml (>51)
Non-reactive
Negative
Non-reactive
Negative
Negative
< 0.2 AI (< 1.0)
< 10.0 IU/ml (< 14.0)
< 0.2 U (< 1.0)
Negative
Negative
0.845 (0.26 – 1.65)
Urine and serum are negative for monoclonal FLC
Not detected
Not detected
<1:128 (<1:128 titer)
<1:20 (<1:20 titer)
Not detected
Negative
Negative
Not detected
None detected
Negative
<1:16 (<1:16)
<1:16 (<1:16)
No Acid Fast bacilli isolated
Negative
No Growth
5309 DNA molecules/mcL (< 10)